NCT05280717 - Relative Bioavailability, Safety, and Tolerability of Single-dose Sotrovimab Injection in Adults (COSMIC) | Biotech Hunter

Enrollment

316

Participants

Timeline

Start Date

March 28, 2022

Primary Completion Date

April 5, 2023

Study Completion Date

November 6, 2023

Conditions

Covid19

Interventions

BIOLOGICAL

sotrovimab

via IM injection

BIOLOGICAL

sotrovimab

via IM injection

BIOLOGICAL

sotrovimab

via IM injection

BIOLOGICAL

sotrovimab

via IM injection

BIOLOGICAL

sotrovimab

via IM injection

BIOLOGICAL

sotrovimab

via IV injection

BIOLOGICAL

sotrovimab

via IV infusion

Trial Locations (10)

13901

Investigative Site, Binghamton

32132

Investigative Site, Edgewater

33462

Investigative Site, Atlantis

63141

Investigative Site, St Louis

73099

Investigative Site, Yukon

77065

Investigative Site, Houston

78745

Investigative Site, Austin

84088

Investigative Site, West Jordan

92503

Investigative Site, Riverside

97504

Investigative Site, Medford